With 70+ lectures, case discussions, and board preparation sessions, this online CME program is an indispensable and comprehensive review of state-of-the-art nephrology practices offered by the clinical faculty of Harvard Medical School.
Intensive Review of Nephrology also offers board review practice sessions and board-relevant Q&As, with a particular focus on acid base and electrolyte disorders, glomerulonephritis, transplantation, renal pathology, and clinical images. Plus, you get valuable continuing medical education insight on:
- Genetic testing for improved prognosis and therapy selection
- Introduction to point-of-care ultrasound: fundamentals for acquisition and interpretation
- Physical exam of the dialysis access
- Expanding the role of SGLT2i in diabetic and non-diabetic kidney disease
- Cases in cryptonephrology
- The new fundamentals in immunology and nephrology (it’s not just for transplant patients)
Learning Objectives
Upon completion of this activity, participants will be able to:
- Summarize current/recommended nephrology guidelines in clinical practice
- Explain the differential diagnosis of complex clinical presentations of patients with renal disorders
- Identify/integrate current therapeutic options for specific renal disorders
- Review and interpret up-to-date literature relevant to clinical practice
- Describe pathophysiological mechanisms as they apply to management of renal disease
- Synthesize teachings to better performance on the ABIM nephrology certification/recertification examinations
TOPICS / SPEAKERS
Renal Physiology for the Boards – Melanie P. Hoenig, MD
Basic Concepts of Immunology in Autoimmune Kidney Disease – Ramon G. Bonegio, MD
Question and Answer Session – Faculty
Renal Pathology in 2021 – Part 1 Nephritic Conditions – Helmut G. Rennke, MD
Renal Pathology in 2021 – Part 2 – Astrid Weins, MD, PhD
Current Approaches to Urine Sediment Analysis – Martina M. McGrath, MB BCh
Question and Answer Session – Faculty
IgA Nephropathy – Gerald B. Appel, MD
Membranous Nephropathy – Laurence H. Beck, Jr., MD, PhD
ANCA Vasculitis – John L. Niles, MD
Question and Answer Session – Faculty
Update on Lupus Nephritis – Gerald B. Appel, MD
Metabolic Management of Kidney Stones – Gary Curhan, MD, ScD
Anemia Management: Update and Best Practices – Ajay K. Singh, MBBS, FRCP (UK), MBA
Question and Answer Session – Faculty
Hyponatremia and Hypernatremia – Sodium Disorders – David B. Mount, MD
Hypokalemia and Hyperkalemia – Potassium Disorders – David B. Mount, MD
Question and Answer Session – Faculty
Acid-Base Disorders Part I – Anion Gap Metabolic Acidosis – Alan S.L. Yu, MB, BChir
Acid-Base Disorders II – Non-Gap Acidosis and Metabolic Alkalosis – Alan S.L. Yu, MB, BChir
Question and Answer Session – Faculty
Treating Renal Patients with Rituximab in the Era of Covid-19 – David B. Mount, MD
Genetics and Kidney Disease – Friedhelm Hildebrandt, MD
Update on Polycystic Kidney Disease – Cristian Riella, MD
Question and Answer Session – Faculty
Pediatric Nephrology – Michael J.G. Somers, MD
Genetics – How to Integrate It into Practice – Ana Onuchic-Whitford, MD
Health Disparities in Chronic Kidney Disease – Lupus Nephritis as a Model Social Determinants, Biology, and Unmet Needs – Winfred W. Williams, Jr., MD
SPECIAL LECTURE — Pig-to-Human Xenotransplantation: NYU Langone Health’s Experience – Robert Montgomery, MD, PhD
Why Do We Reject a Transplant? – Jamil R. Azzi, MD
Transplant Immunosuppression for the Boards – Steven Gabardi, PharmD, BCPS, FAST, FCCP
Question and Answer Session – Faculty
Immunological Assessment Pre and Post Transplant – Melissa Y. Yeung, MD and Indira Guleria, PhD
Early Post-Transplant Management – Anil K. Chandraker, MD
Question and Answer Session – Faculty
Evaluation of the Kidney Living Donor – Kassem Safa, MD
Late Loss of the Kidney Transplant – Andrew S. Allegretti, MD, MSc
Infections in Transplant Recipients – Sarah P. Hammond, MD
Monitoring Kidney Transplant Patients: Beyond Creatinine – Saif Abdulkarim Muhsin, MB BCh
Pre-Transplant Surgical Evaluation of Recipients – Jamil R. Azzi, MD
Question and Answer Session – Faculty
Poisonings and Intoxications: What a Nephrologist Needs to Know – Timothy B. Erickson, MD
Late Post-Transplant Medical Complications – Leonardo V. Riella, MD, PhD
Hemolytic Uremic Syndrome (HUS) and Thrombotic Thrombocytopenic Purpura (TTP) – Jean M. Francis, MD
Geriatric Nephrology – Ernest I. Mandel, MD
Pathophysiology and Treatment of Diabetic Kidney Disease – Gearoid M. McMahon, MB BCh
Management of Hypertension after SPRINT – A Plethora of Guidelines – Richard J. Glassock, MD
Question and Answer Session – Faculty
Secondary Hypertension – Primary Aldosteronism and Pheochromocytoma – Anand Vaidya, MD, MMSc
Cardiorenal Syndrome – Finnian R. McCausland, MB BCh, MMSc, FRCPI
Liver and the Kidney – Andrew S. Allegretti, MD, MSc
Question and Answer Session – Faculty
Pathophysiology of Acute Kidney Injury – Joseph V. Bonventre, MD, PhD
Acute Kidney Injury Syndromes – Alice M. Sheridan, MD
ICU Nephrology and Continuous Renal Replacement Therapies – David J.R. Steele, MB BCh
Question and Answer Session – Faculty
Cancer and Acute Kidney Injury – Albert Q. Lam, MD
Paraprotein Induced Kidney Injury – Albert Q. Lam, MD
Focal and Segmental Glomerulosclerosis (FSGS): A Lesion, Not a Disease – Richard J. Glassock, MD
From Genes to Therapies – Anna Greka, MD, PhD
APOL1 and Kidney Disease – Opeyemi Olabisi, MD, PhD
Question and Answer Session – Faculty
Dialysis Dosing – J. Kevin Tucker, MD
Mineral and Bone Disease – David Bushinsky, MD
Question and Answer Session – Faculty
Dialysis – A Case-Based Clinical Review and Update – J. Kevin Tucker, MD
Pearls in Mineral and Bone Disease – David Bushinsky, MD
Chronic Kidney Disease Epidemiology – A 2022 Update – Gearoid M. McMahon, MB BCh
Question and Answer Session – Faculty
Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC
Peritoneal Dialysis Complications – Joanne M. Bargman, MD, FRCPC
Peritoneal Dialysis: Audience Questions Answered – J. Kevin Tucker, MD
Acute Kidney Injury Related to Immune Checkpoint Inhibitors – Shruti Gupta, MD, MPH
Mesoamerican Nephropathy – Ricardo Correa-Rotter, MD
Renal Ultrasound for the Clinical Nephrologist – Adina S. Voiculescu, MD
Dialysis Vascular Access – Assessment and Complications – Dirk M. Hentschel, MD
Question and Answer Session – Faculty
Glomerulonephritis – Questions & Answers Session – Gerald B. Appel, MD
Must-Know Clinical Images in Nephrology – Ajay K. Singh, MBBS, FRCP (UK), MBA
Electrolytes and Acid-Base Practice for the Boards – Part 1 – Alan S.L. Yu, MB, BChir
Electrolytes and Acid-Base Practice for the Boards – Part 2 – Alan S.L. Yu, MB, BChir
Chronic Kidney Disease in the Community – Meeting Them Where They Are – Li-Li Hsiao, MD, PhD, FACP
COVID-19 Vaccination Response in Transplant Patients – Ann E. Woolley, MD
Update on Renovascular Disease – Joseph M. Garasic, MD
Pre-Transplant Surgical Evaluation of Recipients – Sayeed Malek, MD, FACS
Immunologic Basis of Kidney Disease – Vivek Kasinath, MD
Use of Checkpoint Inhibitors in Kidney Transplant Recipients – Naoka Murakami, MD, PhD
Interstitial Nephritis – Overview for the Boards – Julie M. Paik, MD, ScD, MPH
Ethics in Nephrology – Valerie Luyckx, MD, MB BCh
Pregnancy and Renal Disease – Jessica Tangren, MD
Transplant Cases: Board Review Practice – Melissa Y. Yeung, MD and Edgar L. Milford, Jr., MD
Transplant Board Review – Anil K. Chandraker, MD
Must-Know Board Zebras – Emily S. Robinson, MD, MPH
Nephrology Board Review Practice 1 – Finnian McCausland, MB BCh, MMSc, FRCPI
Nephrology Board Review Practice 2 – Mallika Mendu, MD, MBA
Date of Original Release: September 30, 2022
Termination Date: January 31, 2025
